Ono Pharmaceutical
(OTC) OPHLF
Ono Pharmaceutical Financials at a Glance
Market Cap
$6.84B
Revenue (TTM)
$518.51B
Net Income (TTM)
$70.20B
EPS (TTM)
$0.99
P/E Ratio
14.65
Dividend
$0.52
Beta (Volatility)
0.08 (Low)
Dividend
$0.52
Beta (Volatility)
0.08 (Low)
Price
$14.30
Volume
1,933
Open
$14.30
Price
$14.30
Volume
1,933
Open
$14.30
Previous Close
$14.30
Daily Range
$14.30 - $14.30
52-Week Range
$9.33 - $18.67
Dividend
$0.52
Beta (Volatility)
0.08 (Low)
Price
$14.30
Volume
1,933
Open
$14.30
Previous Close
$14.30
Daily Range
$14.30 - $14.30
52-Week Range
$9.33 - $18.67
OPHLF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ono Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
4,287
CEO
Gyo Sagara
Website
www.ono-pharma.com/jaHeadquarters
Osaka, 541-8564, JP
OPHLF Financials
Key Financial Metrics (TTM)
Gross Margin
73%
Operating Margin
20%
Net Income Margin
14%
Return on Equity
9%
Return on Capital
11%
Return on Assets
6%
Earnings Yield
6.83%
Dividend Yield
3.59%
Payout Ratio
53.80%
Stock Overview
Market Cap
$6.84B
Shares Outstanding
469.91M
Volume
1.93K
Avg. Volume
71.172
Financials (TTM)
Gross Profit
$376.42B
Operating Income
$103.99B
EBITDA
$141.98B
Operating Cash Flow
$137.68B
Capital Expenditure
$6.06B
Free Cash Flow
$131.62B
Cash & ST Invst.
$238.60B
Total Debt
$121.70B
Ono Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$119.50B
+6.4%
Gross Profit
$86.23B
+28.6%
Gross Margin
72.16%
N/A
Market Cap
$6.84B
N/A
Market Cap/Employee
$1.77M
N/A
Employees
3,853
N/A
Net Income
$823.15M
+112.6%
EBITDA
$22.16B
+482.8%
Quarterly Fundamentals
Net Cash
$116.90B
+83.5%
Accounts Receivable
$146.85B
+8.8%
Inventory
$57.81B
-22.8%
Long Term Debt
$82.99B
-26.9%
Short Term Debt
$38.71B
+16.7%
Return on Assets
6.31%
N/A
Return on Invested Capital
10.96%
N/A
Free Cash Flow
$49.42B
+31.5%
Operating Cash Flow
$50.50B
+29.5%
